Original Research

Published on 17 May 2024

Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates

in Vaccines and Molecular Therapeutics

Natalie Kogseder
Viktoria Puxkandl
Wolfram Hoetzenecker
Sabine Altrichter

Frontiers in Immunology

doi 10.3389/fimmu.2024.1324987

1,130 views

Review

Published on 17 May 2024

Single domain antibodies from camelids in the treatment of microbial infections

in Vaccines and Molecular Therapeutics

Henri De Greve
Antonella Fioravanti

Frontiers in Immunology

doi 10.3389/fimmu.2024.1334829

2,673 views

Original Research

Published on 15 May 2024

Tissue-specific sex differences in pediatric and adult immune cell composition and function

in Vaccines and Molecular Therapeutics

Mahina Tabassum Mitul
Jenna M. Kastenschmidt
Suhas Sureshchandra
Zachary W. Wagoner
Andrew M. Sorn
David R. Mcllwain
Jenny E. Hernandez-Davies
Aarti Jain
Rafael de Assis
Douglas Trask

Frontiers in Immunology

doi 10.3389/fimmu.2024.1373537

2,238 views
2 citations

Original Research

Published on 15 May 2024

Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5- specific response

in Vaccines and Molecular Therapeutics

Ryan Baker
Rebecca Lawlor
Maeve Smith
Jessica Price
Ashley Eaton
Andrew Lover
Dominique Alfandari
Peter Reinhart
Kathleen F. Arcaro
Barbara A. Osborne

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401209

1,249 views

Original Research

Published on 15 May 2024

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents

in Vaccines and Molecular Therapeutics

Daniela Rivera-Pérez
Constanza Méndez
Benjamín Diethelm-Varela
Felipe Melo-González
Yaneisi Vázquez
Xing Meng
Qianqian Xin
Rodrigo A. Fasce
Jorge Fernández
Judith Mora

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372193

1,710 views

Original Research

Published on 14 May 2024

Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells

in Vaccines and Molecular Therapeutics

Kilian A. Wietschel
Kevin Fechtner
Elmer Antileo
Goran Abdurrahman
Chiara A. Drechsler
Michelle Kudzayi Makuvise
Ruben Rose
Mathias Voß
Andi Krumbholz
Stephan Michalik

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382911

3,358 views
3 citations

Original Research

Published on 14 May 2024

Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina

in Vaccines and Molecular Therapeutics

Arnulfo Garza-Silva
Diego Rivera-Salinas
Andrea Rivera-Cavazos
Iván Francisco Fernández-Chau
Andrea Belinda Cepeda-Medina
Devany Paola Morales-Rodríguez
Irene Antonieta Barco-Flores
Miguel Ángel Sanz-Sánchez
Cecilia Acciardi
Graciela Paez-Bo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403784

1,331 views

Original Research

Published on 13 May 2024

Polish regulatory system regarding ATMP hospital exemptions

in Vaccines and Molecular Therapeutics

Jan Pachocki
Frances Verter

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379134

1,335 views
1 citation

Brief Research Report

Published on 13 May 2024

Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in Korea: interim analysis

in Vaccines and Molecular Therapeutics

Eliel Nham
Jang Wook Sohn
Won Suk Choi
Seong-Heon Wie
Jacob Lee
Jin-Soo Lee
Hye Won Jeong
Joong Sik Eom
Yu Jung Choi
Hye Seong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382944

2,644 views

Original Research

Published on 10 May 2024

Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine

in Vaccines and Molecular Therapeutics

Alaa Karkashan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395870

1,791 views

Original Research

Published on 10 May 2024

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates

in Vaccines and Molecular Therapeutics

Marco Polo Peralta Alvarez
Holly Jones
Hugo Redondo Azema
Chloe Davis
Andrew D. White
Charlotte Sarfas
Mike Dennis
Shuailin Li
Daniel Wright
Eugenia Puentes

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387454

1,905 views
1 citation

Original Research

Published on 10 May 2024

A TLR4 ligand-based adjuvant for promoting the immunogenicity of typhoid subunit vaccines

in Vaccines and Molecular Therapeutics

Kishore R. Alugupalli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383476

994 views
1 citation

Original Research

Published on 08 May 2024

The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort

in Vaccines and Molecular Therapeutics

Jennifer Serwanga
Laban Kato
Gerald Kevin Oluka
Violet Ankunda
Jackson Sembera
Claire Baine
Isaac Kitabye
Angela Namuyanja
Solomon Opio
Joseph Ssebwana Katende

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384668

1,116 views

Original Research

Published on 08 May 2024

Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities

in Vaccines and Molecular Therapeutics

Jéromine Klingler
Shreyas Kowdle
Juan C. Bandres
Rozita Emami-Gorizi
Raymond A. Alvarez
Priyanka G. Rao
Fatima Amanat
Charles Gleason
Giulio Kleiner
Viviana Simon

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382619

1,590 views

Original Research

Published on 08 May 2024

BacScan: a novel genome-wide strategy for uncovering broadly immunogenic proteins in bacteria

in Vaccines and Molecular Therapeutics

Junhua Dong
Qian Zhang
Jinyue Yang
Yacan Zhao
Zhuangxia Miao
Siyang Pei
Huan Qin
Changwei Jing
Guoyuan Wen
Anding Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1392456

1,756 views

Original Research

Published on 07 May 2024

Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status

in Vaccines and Molecular Therapeutics

Jolanda Brummelman
Sara Suárez-Hernández
Lia de Rond
Marjan Bogaard-van Maurik
Petra Molenaar
Emma van Wijlen
Debbie Oomen
Lisa Beckers
Nynke Y. Rots
Josine van Beek

Frontiers in Immunology

doi 10.3389/fimmu.2024.1392477

2,017 views

Navigation group

Articles

Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates

Single domain antibodies from camelids in the treatment of microbial infections

Tissue-specific sex differences in pediatric and adult immune cell composition and function

Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5- specific response

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents

Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination – kinetics of plasma antibodies, plasmablasts and memory B cells

Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and Argentina

Polish regulatory system regarding ATMP hospital exemptions

Effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine in Korea: interim analysis

Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates

A TLR4 ligand-based adjuvant for promoting the immunogenicity of typhoid subunit vaccines

The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort

Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities

BacScan: a novel genome-wide strategy for uncovering broadly immunogenic proteins in bacteria

Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status